Opportunity Information: Apply for PAR 14 356
Apply for PAR 14 356
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "The Midlife in the United States Study (U19)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866 Aging Research.
- This funding opportunity was created on Oct 14, 2014 and posted on Oct 2, 2014.
- Applicants must submit their applications by Sep 26, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) State governments Public housing authorities/Indian housing authorities Private institutions of higher education City or township governments For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Midlife in the United States Study (MIDUS) U19 opportunity (Funding Opportunity Number PAR 14 356) is a National Institutes of Health cooperative agreement designed to support the next five year cycle of MIDUS, a major national longitudinal study focused on health and well being across midlife and beyond. The core aim of this funding is to keep the MIDUS cohort moving forward as a long running research platform by completing key pending data collection waves, expanding scientific content in targeted areas, and ensuring that the resulting data remain widely usable by the broader research community through strong dissemination and user support.
A central deliverable for the next phase is completion of the third wave of longitudinal MIDUS data collection. This is essentially the next major follow up of participants, allowing researchers to study how health, psychological factors, social life, and economic circumstances change over time within the same individuals. Longitudinal follow up is what gives MIDUS much of its value, since it supports questions about trajectories and timing (for example, how earlier life stress relates to later cardiovascular risk, or how changes in work and family roles shape well being as people age).
The FOA also calls for enhancing MIDUS content related to daily stress. That emphasis signals continued development of measurement approaches that capture stress as it is experienced in everyday life, not only as a retrospective summary. Daily stress data often allow more precise links between short term experiences (like daily hassles, conflict, workload, caregiving strain, or sleep disruption) and outcomes such as mood, cognition, inflammation, health behaviors, and longer term disease risk. Strengthening this area increases the study's ability to connect real world exposures with both psychological and biological responses.
Another major requirement is completing the second wave of data collection for clinical biomarkers and affective neuroscience assessments. In practice, this means continuing and expanding MIDUS's integration of traditional survey and psychosocial measures with objective indicators of health and functioning. Clinical biomarkers can include physiological measures relevant to aging and chronic disease risk, while affective neuroscience components can support research on emotion related brain and behavioral processes. The second wave aspect is important because repeated biological and neuroscience measurement allows researchers to examine change, stability, and cumulative risk, rather than relying on a single snapshot.
The announcement highlights continued support for innovative sub studies, including work on how psychosocial influences affect gene expression. This points to MIDUS's role in linking social and psychological experiences with molecular and biological pathways, a line of research often associated with questions about stress biology, immune functioning, and mechanisms through which life context "gets under the skin." The FOA also explicitly encourages novel methods to track and reinstate non responders, reflecting a practical but scientifically critical goal: maintaining cohort participation and reducing attrition bias. Better retention and re engagement methods help preserve representativeness and statistical power, and they protect the integrity of long term inference.
Beyond collecting new data, the FOA emphasizes connecting these content areas through innovative analyses across multiple domains already central to MIDUS. Applicants are expected to integrate and link information on health and physical functioning, personality and psychological characteristics, cognitive status, affective functioning, economic well being, social relationships, and broader well being outcomes. The intent is not simply parallel data streams, but coordinated science that can examine interactions across levels (social, psychological, behavioral, and biological) and across time. This kind of integration is what enables MIDUS to serve as a shared national resource for research on aging, resilience, inequality, and health disparities.
Data dissemination is treated as a central goal rather than an afterthought. The FOA stresses maintaining and enhancing data distribution and user support, specifically supporting public use files and encouraging broad scientific use. In other words, the award is meant to sustain MIDUS not only as a study that collects data, but also as an infrastructure that curates, documents, and shares the data in ways that make it feasible for outside investigators to conduct high quality analyses. Strong user support typically implies clear documentation, harmonized variables across waves, guidance on complex data components (like biomarker and neuroscience measures), and systems that help researchers access and use the data responsibly and efficiently.
From an administrative standpoint, this is a discretionary funding opportunity using a cooperative agreement mechanism (U19), meaning NIH expects substantial programmatic involvement compared with a standard research project grant. The activity category is Health, with the CFDA number 93.866 (Aging Research). There is no cost sharing or matching requirement. The opportunity was posted October 2, 2014, created October 14, 2014, and had a final closing date of September 26, 2017 (with an archive date of February 7, 2018).
Eligibility is broad across government, academic, nonprofit, and certain for profit entities, including public and state controlled and private institutions of higher education, nonprofits (including 501(c)(3) and certain non 501(c)(3) organizations), small businesses, and multiple levels of government (state, county, city or township, special districts, and housing authorities). It also lists eligibility for several mission specific institution types such as HBCUs, Hispanic serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, and AANAPISI institutions, as well as faith based or community based organizations and eligible federal agencies. At the same time, the FOA clearly excludes non U.S. entities: foreign organizations and foreign institutions are not eligible to apply, non U.S. components of U.S. organizations are not eligible, and foreign components (as defined in NIH policy) are not allowed.
For reference, the full announcement was hosted by NIH at http://grants.nih.gov/grants/guide/pa files/PAR 14 356.html, and NIH provided an Office of Extramural Research contact for access or linking issues via FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the MIDUS U19 funding opportunity (PAR 14 356)?
The Midlife in the United States Study (MIDUS) U19 opportunity (Funding Opportunity Number PAR 14 356) is a National Institutes of Health (NIH) cooperative agreement intended to support the next five-year cycle of MIDUS, a major national longitudinal study focused on health and well-being across midlife and beyond.
What is the overall purpose of this FOA?
The core purpose is to keep the MIDUS cohort moving forward as a long-running research platform by (1) completing key pending data collection waves, (2) expanding scientific content in targeted areas, and (3) ensuring the resulting data remain widely usable by the broader research community through strong dissemination and user support.
What is the central deliverable in the next phase of MIDUS under this opportunity?
A central deliverable is completion of the third wave of longitudinal MIDUS data collection, which serves as the next major follow-up of participants and enables analyses of change over time within the same individuals.
Why is completing the third wave of longitudinal data collection important?
Longitudinal follow-up is a major source of MIDUS value because it supports research on trajectories and timing, such as how earlier life stress relates to later cardiovascular risk or how changes in work and family roles shape well-being as people age.
Does the FOA include a focus on daily stress, and what does that mean?
Yes. The FOA calls for enhancing MIDUS content related to daily stress, emphasizing measurement approaches that capture stress as it is experienced in everyday life rather than only through retrospective summaries.
What kinds of questions can stronger daily stress measurement help address?
Daily stress data can support more precise links between short-term experiences (for example, daily hassles, conflict, workload, caregiving strain, or sleep disruption) and outcomes such as mood, cognition, inflammation, health behaviors, and longer-term disease risk.
What biomarker and neuroscience work is required by this FOA?
The FOA requires completing the second wave of data collection for clinical biomarkers and affective neuroscience assessments, continuing MIDUS efforts to integrate survey and psychosocial measures with objective indicators of health and functioning.
Why does the FOA emphasize a second wave of biomarkers and affective neuroscience assessments?
Repeated biological and neuroscience measurement allows researchers to examine change, stability, and cumulative risk over time, rather than relying on a single point-in-time snapshot.
Does this opportunity support innovative sub-studies?
Yes. The announcement highlights continued support for innovative sub-studies, including work examining how psychosocial influences affect gene expression.
How does the FOA describe gene expression-related sub-studies in the MIDUS context?
The FOA frames this as linking social and psychological experiences with molecular and biological pathways, often associated with stress biology, immune functioning, and mechanisms through which life context can "get under the skin."
Is participant retention addressed in the FOA?
Yes. The FOA explicitly encourages novel methods to track and reinstate non-responders, emphasizing the importance of maintaining cohort participation and reducing attrition bias.
Why is tracking and reinstating non-responders scientifically important for MIDUS?
Better retention and re-engagement methods help preserve representativeness and statistical power, and help protect the integrity of long-term inference in a longitudinal cohort.
Does the FOA expect integration across different domains of MIDUS data?
Yes. Beyond collecting new data, the FOA emphasizes connecting content areas through innovative analyses across multiple domains already central to MIDUS, with an expectation that information is integrated rather than maintained as parallel, unconnected streams.
Which domains are specifically mentioned as areas to integrate and link?
The FOA mentions integrating and linking information on health and physical functioning, personality and psychological characteristics, cognitive status, affective functioning, economic well-being, social relationships, and broader well-being outcomes.
What is the intended scientific value of integrating across these domains?
This coordinated approach enables analyses of interactions across levels (social, psychological, behavioral, and biological) and across time, reinforcing MIDUS as a shared national resource for research on aging, resilience, inequality, and health disparities.
How important is data dissemination in this FOA?
Data dissemination is treated as a central goal. The FOA stresses maintaining and enhancing data distribution and user support, specifically supporting public use files and encouraging broad scientific use.
What does "user support" imply in the context of MIDUS dissemination?
As described, strong user support typically implies clear documentation, harmonized variables across waves, guidance on complex data components (including biomarker and neuroscience measures), and systems that help researchers access and use the data responsibly and efficiently.
What type of funding mechanism is used for this opportunity?
This is a discretionary funding opportunity using a cooperative agreement mechanism (U19), meaning NIH expects substantial programmatic involvement compared with a standard research project grant.
What is the activity category and CFDA number listed for this opportunity?
The activity category is Health, and the CFDA number is 93.866 (Aging Research).
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
When was this opportunity posted and what are the close/archive dates?
The opportunity was posted on October 2, 2014, created on October 14, 2014, had a final closing date of September 26, 2017, and an archive date of February 7, 2018.
Who is eligible to apply?
Eligibility is broad across government, academic, nonprofit, and certain for-profit entities. Eligible applicants include public and state controlled and private institutions of higher education; nonprofits (including 501(c)(3) and certain non-501(c)(3) organizations); small businesses; and multiple levels of government (state, county, city or township, special districts, housing authorities). The FOA also lists mission-specific institution types such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian-serving institutions, and AANAPISI institutions, as well as faith-based or community-based organizations and eligible federal agencies.
Are foreign organizations or non-U.S. entities allowed to apply?
No. The FOA excludes non-U.S. entities: foreign organizations and foreign institutions are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined in NIH policy) are not allowed.
Where can the full NIH announcement be found?
The full announcement was hosted by NIH at http://grants.nih.gov/grants/guide/pa-files/PAR-14-356.html
Who do you contact for access or linking issues related to the announcement page?
NIH provided an Office of Extramural Research contact for access or linking issues via FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Health
Next opportunity: Resource Program Grants in Bioinformatics (P41)
Previous opportunity: Pre Symptomatic Profiles of Chronic Lung Disease(s) from Retrospective Cohorts (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 14 356
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 14 356) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening the Capacity of the Republican Blood Center to Scale Up Blood Safety Program in the Kyrgyzstan Republic under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CC RFA GH15 1512 Funding Number: CC RFA GH15 1512 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Strengthening the Capacity of the Republican Blood Center to Scale Up Blood Safety Program in Tajikistan (TJ) under the President Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1513 Funding Number: CDC RFA GH15 1513 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Strengthening HIV Clinical Services in the Republic of Rwanda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1567 Funding Number: CDC RFA GH15 1567 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $30,000,000 |
| Building Sustainable Capacity of the Ministry of Home Affairs to Address HIV and TB Prevention, Care and Treatment in Zambian Prisons and Respond to Child Sexual Abuse and Sexual Gender Based Violence in the Republic of Zambia under the Presidents Em Apply for CDC RFA GH15 1601 Funding Number: CDC RFA GH15 1601 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Definition of Resilience and Pre Symptomatic Disease in Lung Health and Disease (R01) Apply for RFA HL 15 024 Funding Number: RFA HL 15 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technical Assistance to Support the Implementation and Evaluation of HIV/AIDS Prevention, Care, Treatment, and Support Activities for Mothers, Children, and Families under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1531 Funding Number: CDC RFA GH15 1531 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $6,000,000 |
| Strengthening Blood Transfusion Services in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1559 Funding Number: CDC RFA GH15 1559 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Regional Consortia for High Resolution Cryoelectron Microscopy (U24) Apply for RFA GM 16 001 Funding Number: RFA GM 16 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ensuring Reliable and Equitable Access to PMTCT Services for Key Populations in the Republic of Mali under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1605 Funding Number: CDC RFA GH15 1605 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Biology of the Temporomandibular Joint in Health and Disease (R01) Apply for PA 14 358 Funding Number: PA 14 358 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthen the Capacity of the Republic of Malis National Institute for Public Health Research (INRSP) to Implement Laboratory Based Activities and Research in Support of STI/HIV Prevention and Care Services under the Presidents Emergency Plan for AI Apply for CDC RFA GH15 1606 Funding Number: CDC RFA GH15 1606 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Biology of the Temporomandibular Joint in Health and Disease (R21) Apply for PA 14 359 Funding Number: PA 14 359 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Support the Ministry of Health (MOH) to Scale up and Improve HIV/AIDS Prevention, Care, and Treatment Services in the Kingdom of Lesotho under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1547 Funding Number: CDC RFA GH15 1547 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Zambia DISCOVER H Apply for 611 DRAFT PROGRAM DESCRIPTION 001 Funding Number: 611 DRAFT PROGRAM DESCRIPTION 001 Agency: Zambia USAID Lusaka Category: Health Funding Amount: $60,000,000 |
| R40 Maternal and Child Health Research Program (MCHR) Apply for HRSA 15 062 Funding Number: HRSA 15 062 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| R40 Maternal and Child Health Research Program (SDAS) Apply for HRSA 15 077 Funding Number: HRSA 15 077 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| Service Area Competition Apply for HRSA 15 014 Funding Number: HRSA 15 014 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Hepatitis C Cooperative Research Centers Immunity to HCV Infection (U19) Apply for RFA AI 14 045 Funding Number: RFA AI 14 045 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| System Level Health Services and Policy Research on Health Disparities (R01) Apply for RFA MD 15 001 Funding Number: RFA MD 15 001 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| NIMHD Academic Research Enhancement Award Enhancing Health Disparities Research at Undergraduate Institutions (R15) Apply for RFA MD 15 002 Funding Number: RFA MD 15 002 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 14 356", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
